Annual report
6788.TEDINET S100W12R
Period2024-04-01 → 2025-03-31
Filed2025-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥18.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.3bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥3.1bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.5bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.5bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥35.4bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥31.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥29.0bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥26.6bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.9bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.8bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥25.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥23.6bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥22.1bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥20.8bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥17.8bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.4bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥9.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥883m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥551m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥432m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥887m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥553m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥998m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥500m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥568m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥109m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥292.41 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥280.51 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥214.78 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.58 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥195.45 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,125.8 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,911.21 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,743.39 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,585.01 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,239.7 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 67.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.4% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.7% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.9% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 735 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 663 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 650 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 608 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 576 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥15.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥15.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥14.0bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥2.2bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.6bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.2bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.3bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.6bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥22.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥21.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥20.1bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.5bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.7bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥18.9bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥18.0bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥17.3bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥16.7bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥16.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.4bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥207.17 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.11 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.93 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.33 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥131.51 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥130 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥85 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥120 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,461.1 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,344.3 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,261.46 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,172.44 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,130.05 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.2% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,656,780 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 342 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 326 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 325 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 321 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 327 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥15m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥1.4bn |
| Medical Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥710m |
| Medical Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥127m |
| Medical Relatedreportable segment | employees | at 2025-03-31 | 126 pure |
| Medical Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| Medical Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| Medical Relatedreportable segment | segment assets | at 2025-03-31 | ¥8.0bn |
| Medical Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥390m |
| Water Health Carereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥353m |
| Water Health Carereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥329m |
| Water Health Carereportable segment | employees | at 2025-03-31 | 609 pure |
| Water Health Carereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥19.6bn |
| Water Health Carereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥19.6bn |
| Water Health Carereportable segment | segment assets | at 2025-03-31 | ¥25.9bn |
| Water Health Carereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥456m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥22.5bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥22.5bn |
| —segment total | segment assets | at 2025-03-31 | ¥33.9bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥3.3bn |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥14m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥1.4bn |
| Medical Relatedreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥148m |
| Medical Relatedreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥121m |
| Medical Relatedreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.6bn |
| Medical Relatedreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.6bn |
| Medical Relatedreportable segment | segment assets | at 2024-03-31 | ¥7.2bn |
| Medical Relatedreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥392m |
| Water Health Carereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥281m |
| Water Health Carereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥305m |
| Water Health Carereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥17.8bn |
| Water Health Carereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥17.8bn |
| Water Health Carereportable segment | segment assets | at 2024-03-31 | ¥22.9bn |
| Water Health Carereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥2.7bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥428m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥426m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥20.4bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥20.4bn |
| —segment total | segment assets | at 2024-03-31 | ¥30.1bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥3.1bn |
| Medical Relatedreportable segment | employees | at 2025-03-31 | 4 pure |
| Water Health Carereportable segment | employees | at 2025-03-31 | 338 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,550
| Item | Context | Value | Unit |
|---|---|---|---|
| Provision for bonuses | Prior1YearInstant | 185000000 | JPY |
| Provision for bonuses | CurrentYearInstant | 200425000 | JPY |
| Provision for product warranties | Prior1YearInstant | 84000000 | JPY |
| Provision for product warranties | CurrentYearInstant | 85000000 | JPY |
| Other cl | Prior1YearInstant | 1368342000 | JPY |
| Other cl | CurrentYearInstant | 1612642000 | JPY |
| Current liabilities | Prior1YearInstant | 6630202000 | JPY |
| Current liabilities | CurrentYearInstant | 7155031000 | JPY |
| Long term loans payable | Prior1YearInstant | － | JPY |
| Long term loans payable | CurrentYearInstant | 1131089000 | JPY |
| Provision for share based payments ncl | Prior1YearInstant | 88800000 | JPY |
| Provision for share based payments ncl | CurrentYearInstant | 177454000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 299572000 | JPY |
| Provision for directors retirement benefits | CurrentYearInstant | 260406000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 407417000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 367842000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 56079000 | JPY |
| Asset retirement obligations ncl | CurrentYearInstant | 64192000 | JPY |
| Other ncl | Prior1YearInstant | 435342000 | JPY |
| Other ncl | CurrentYearInstant | 651593000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1287211000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 2652578000 | JPY |
| Liabilities | Prior1YearInstant | 7917414000 | JPY |
| Liabilities | CurrentYearInstant | 9807610000 | JPY |
| Capital stock | Prior1YearInstant | 992597000 | JPY |
| Capital stock | CurrentYearInstant | 992597000 | JPY |
| Capital surplus | Prior1YearInstant | 1823945000 | JPY |
| Capital surplus | CurrentYearInstant | 1864182000 | JPY |
| Retained earnings | Prior1YearInstant | 22838855000 | JPY |
| Retained earnings | CurrentYearInstant | 24391935000 | JPY |
| Treasury stock | Prior1YearInstant | -3448320000 | JPY |
| Treasury stock | CurrentYearInstant | -3408285000 | JPY |
| Shareholders equity | Prior1YearInstant | 22207077000 | JPY |
| Shareholders equity | CurrentYearInstant | 23840429000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 64947000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | -14881000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 49075000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | 108612000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -6603000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | 33004000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 107420000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 126735000 | JPY |
| Non controlling interests | Prior1YearInstant | 1312848000 | JPY |
| Non controlling interests | CurrentYearInstant | 1579004000 | JPY |
| Net assets | Prior1YearInstant | 23627347000 | JPY |
| Net assets | CurrentYearInstant | 25546169000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 31544761000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 35353779000 | JPY |
| Net sales | Prior1YearDuration | 20414865000 | JPY |
| Net sales | CurrentYearDuration | 22463830000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |